Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
With your help, we can change the future of healthcare! The Cedars-Sinai Biomanufacturing Center (CBC) is a state-of-the art facility that comprises of a cGMP cell manufacturing facility housing
-
the spatial and functional relationship between cancer cells and the immune cells contained within the tumor microenvironment. By identifying pathways of resistance, we aim to develop novel therapies
-
planning, experimental protocols & procedures, and administration of day-to-day lab operations. The RS III utilizes a solid foundation in research and experience with techniques associated with a specific
-
motivated Research Associate II interested in the innate inflammatory responses of myeloid cells to join the Department of Biomedical Sciences and the Inflammatory Bowel Disease Institute (IBDI) at Cedars
-
to Western, Northern blot, DNA/RNA, PCR, protein extraction, cell culture, Immunohistochemistry, and staining. This position does not have supervisory responsibilities. What are the Primary Duties and
-
single cell omics, spatial transcriptomics, and bulk cell omics. We specialize in single cell omics and spatial transcriptomics via the 10x Genomics, Parse Biosciences, Mission Bio, and NanoString
-
at least 1 year of previous lab experience). - Technical proficiency in cell culture and hands-on mouse work (s.c, i.v, i.p. injections). Previous experience in mouse work is preferred, but not
-
for the treatment of autologous and allogeneic stem cells, bone marrow transplant, and umbilical cord blood transplant patients. The average daily census is 31. We use a multi-disciplinary approach to patient care
-
bladder cancer development by interacting with tumor microenvironment including fibroblasts and immune cells. Main research directions in the lab include: The role of protein biomarkers in the development
-
or aged tissues through either revitalizing existing cells or transplanting new ones. At the Board of Governors Regenerative Medicine Institute, researchers are turning stem cells into therapies